Immunotherapy for Patients with Resectable NSCLC and a Driver Mutation
Oct 10, 2023 ·
2m 4s
Dr. Joshua Reuss explains why immunotherapy is not typically given to patients with resectable NSCLC and a driver mutation.
Information
| Author | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
